Die fokale Therapie des Prostatakarzinoms gehört zu den aktuellen Innovationen in der Urologie. Ihr Ansatz: Tumorgewebe eliminieren ohne umgebende Strukturen zu schädigen. Jedoch sollten Patienten unter dieser Therapie derzeit noch in Studienprotokolle eingebunden sein.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Klotz L et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1): 126–31.
Weinreb JC et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol. 2016;69(1):16–40.
Hernandez Dj et al. Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy. Urology. 2008;72(1):172–6.
Ross HM et al. Do adenocarcinomas of the prostate with Gleason score (GS)</=6 have the potential to metastasize to lymph nodes? Am J Surg Pathol. 2012;36(9):1346–52.
Marshall S, Taneja S, Focal therapy for prostate cancer: The current status. Prostate Int. 2015;3(2):35–41.
Isbarn H et al. Unilateral prostate cancer cannot be accurately predicted in low-risk patients. Int J Radiat Oncol Biol Phys. 2010;77(3):784–7.
Onik G, Miessau M, Bostwick DG. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol. 2009;27(26):4321–6.
Barentsz JO et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746–57.
Noguchi, M et al. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol. 2003;170(2 Pt 1):459–63.
Ahmed HU. The index lesion and the origin of prostate cancer. N Engl J Med. 2009;361(17): 1704–6.
Le JD et al. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol. 2015;67(3):569–76.
Radtke JP et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. 2016; doi:10.1016/j.eururo.2015.12.052.
De la Rosette J et al. Focal therapy in prostate cancer-report from a consensus panel. J Endourol. 2010;24(5):775–80.
Donaldson IA et al. Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting. Eur Urol. 2015;67(4):771–7.
Van den Bos W et al. Focal therapy in prostate cancer: international multidisciplinary consensus on trial design. Eur Urol. 2014;65(6):1078–83.
Klotz L. Active surveillance and focal therapy for low-intermediate risk prostate cancer. Transl Androl Urol. 2015;4(3):342–54.
Ahmed HU et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol. 2012;13(6):622–32.
Bahn D et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol. 2012;62(1):55–63.
El Fegoun AB et al. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up. Int Braz J Urol. 2011;37(2):213–9;discussion 220-2.
Lindner U et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol. 2009;182(4):1371–7.
Onik G et al. „Male lumpectomy“: focal therapy for prostate cancer using cryoablation. Urology. 2007;70(6 Suppl):16–21.
Oto, A et al. MR imaging-guided focal laser ablation for prostate cancer: phase I trial. Radiology. 2013;267(3):932–40.
Van Velthoven R et al. A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer. Prostate Cancer Prostatic Dis. 2016;19(1):79–83.
Feijoo ER et al. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Eur Urol. 2016;69(2):214–20.
Valerio M et al. The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol. 2014;66(4):732–51.
Wendler JJ et al. [Irreversible electroporation. Current value for focal treatment of prostate cancer]. Urologe A. 2015;54(6):854–62.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ganzer, R., Baumunk, D., Blana, A. et al. Therapieerfolg nur durch präzise Tumorlokalisation möglich. Uro-News 20, 18–26 (2016). https://doi.org/10.1007/s00092-016-1106-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00092-016-1106-x